Switch to:
More From Other Websites
Baxter (BAX) Files for European Approval of PI Treatment - Analyst Blog May 22 2015
Why Baxter May Be Very Undervalued Into Breakup May 21 2015
Baxter BioScience Files for European Approval of Investigational 20% Subcutaneous Immune Globulin... May 21 2015
Baxter BioScience Files for European Approval of Investigational 20% Subcutaneous Immune Globulin... May 21 2015
Baxter's Spain Plant FDA-Approved for Saline Production - Analyst Blog May 20 2015
Goldman Sachs Just Endorsed These 10 Dividend Growth Stocks May 20 2015
Novo Nordisk, Baxter clash over haemophilia drug patent May 20 2015
Novo Nordisk rejects Baxter patent claim over Novoeight May 20 2015
Baxter, Baxalta Provide Business Outlook as Spin-Off Nears - Analyst Blog May 19 2015
Baxter and Baxalta Highlight Business Strategies at Investor Conferences May 18 2015
Baxter and Baxalta Highlight Business Strategies at Investor Conferences May 18 2015
Baxter Receives U.S. FDA Approval for 0.9% Sodium Chloride Injection, USP from Sabinanigo, Spain,... May 15 2015
Baxter Receives U.S. FDA Approval for 0.9% Sodium Chloride Injection, USP from Sabinanigo, Spain,... May 15 2015
Baxter Boosts Oncology Pipeline With $900M Cross-Border Deal May 14 2015
Baxter Looks to Expand in Oncology; Acquires New Portfolio - Analyst Blog May 13 2015
BAXTER INTERNATIONAL INC Financials May 13 2015
Economists Anthony Culyer and Alan Maynard Named Co-Recipients of the 2015 William B. Graham Prize... May 13 2015
Economists Anthony Culyer and Alan Maynard Named Co-Recipients of the 2015 William B. Graham Prize... May 13 2015
Moody's: Baxter's Acquisition of Oncaspar is Credit Negative May 12 2015
REUTERS BUSINESS NEWS SCHEDULE 1830 GMT/2:30 PM ET May 12 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Sww
ReplySww - 10 months ago
Bax medical devices revenue ~9b, bio science ~7b
using 3X sales of medical devices company and 4X for drugs company, 27b+28b = 55b market cap,as of June 2014, BAX market cap is 39b, so it can sell for

72 * (1 + 16/39) = 99

72 is current stock price, with an upside of around 35%

so my guess is BAX may be able to sell for around 90 after spin-off.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK